mhurhangee/patent-ind-claim-en huggingface dataset:
A computer-implemented method, comprising: receiving an anatomical map of at least a portion of a heart ; receiving, for at least a region of the anatomical map, positions and respective bipolar intracardiac electrogram (EGM) signals measured at the positions ; identifying in the bipolar intracardiac EGM signals primary activations and secondary activations, wherein identifying the primary activations and the secondary activations in a bipolar intracardiac EGM signal among the bipolar intracardiac EGM signals comprises: (i) selecting a noise level for the bipolar intracardiac EGM signal; (ii) labeling local maxima of the bipolar intracardiac EGM signal, which are above the selected noise level, as activations; and (iii) for a given cardiac cycle, labeling an activation having a maximum absolute value as a primary activation, and labeling other activations as secondary activations; deriving a surface representation of the bipolar intracardiac EGM signals over the region, including the identified primary activations and secondary activations ; and presenting the surface representation overlaid on the anatomical map . receiving an anatomical map of at least a portion of a heart ; receiving, for at least a region of the anatomical map, positions and respective bipolar intracardiac electrogram (EGM) signals measured at the positions ; identifying in the bipolar intracardiac EGM signals primary activations and secondary activations, wherein identifying the primary activations and the secondary activations in a bipolar intracardiac EGM signal among the bipolar intracardiac EGM signals comprises: (i) selecting a noise level for the bipolar intracardiac EGM signal; (ii) labeling local maxima of the bipolar intracardiac EGM signal, which are above the selected noise level, as activations; and (iii) for a given cardiac cycle, labeling an activation having a maximum absolute value as a primary activation, and labeling other activations as secondary activations; (i) selecting a noise level for the bipolar intracardiac EGM signal; (ii) labeling local maxima of the bipolar intracardiac EGM signal, which are above the selected noise level, as activations; and (iii) for a given cardiac cycle, labeling an activation having a maximum absolute value as a primary activation, and labeling other activations as secondary activations; deriving a surface representation of the bipolar intracardiac EGM signals over the region, including the identified primary activations and secondary activations ; and presenting the surface representation overlaid on the anatomical map .
A refrigerant or heat transfer fluid composition comprising 1,1,1,4,4,4-hexafluoro-2-butene.
A particulate water-absorbing agent comprising a polyacrylic acid (salt)-based water-absorbing resin as a main component, said particulate water-absorbing agent satisfying (a) through (d) below: (a) EXI represented by the following Formula is not less than 11.5: EXI = centrifuge retention capacity / Ln water-soluble component amount wherein the water-soluble component amount is an amount in weight% of dissolved polymer which is determined by pH titration after adding 1.0 g of a water-absorbing resin to 184.3 g of a 0.9 weight% aqueous sodium chloride solution and stirring the resulting mixture at 500 rpm for 16 hours; (b) a molecular weight distribution, represented by the following Formula , of a water-soluble component is 1.0 to 4.8: Molecular weight distribution = weight average molecular weight / number average molecular weight (c) a weight average molecular weight after a hydrolysis treatment is 450,000 Da to 1,800,000 Da, and (d) a branching density after the hydrolysis treatment is not more than 0.100, wherein the branching density is determined in accordance with the method of measurement described in the description; said hydrolysis treatment being a treatment carried out by allowing said particulate water-absorbing agent to swell in a 0.9 weight% aqueous sodium chloride solution, removing the water-soluble component so as to obtain a gel, and allowing 600 mg of the gel to stand still in 10 mL of a 0.1 N aqueous sodium hydroxide solution at 80°C for 3 weeks. (a) EXI represented by the following Formula is not less than 11.5: EXI = centrifuge retention capacity / Ln water-soluble component amount wherein the water-soluble component amount is an amount in weight% of dissolved polymer which is determined by pH titration after adding 1.0 g of a water-absorbing resin to 184.3 g of a 0.9 weight% aqueous sodium chloride solution and stirring the resulting mixture at 500 rpm for 16 hours; (b) a molecular weight distribution, represented by the following Formula , of a water-soluble component is 1.0 to 4.8: Molecular weight distribution = weight average molecular weight / number average molecular weight (c) a weight average molecular weight after a hydrolysis treatment is 450,000 Da to 1,800,000 Da, and (d) a branching density after the hydrolysis treatment is not more than 0.100, wherein the branching density is determined in accordance with the method of measurement described in the description; said hydrolysis treatment being a treatment carried out by allowing said particulate water-absorbing agent to swell in a 0.9 weight% aqueous sodium chloride solution, removing the water-soluble component so as to obtain a gel, and allowing 600 mg of the gel to stand still in 10 mL of a 0.1 N aqueous sodium hydroxide solution at 80°C for 3 weeks.
Object recognition apparatus for vehicles , having at least one sensor in the form of an ultrasonic sensor, a filter device , wherein the sensor and the filter device can be arranged in a common housing, and an analysis device, wherein the sensor is configured to capture signals from at least one ultrasonic detection sequence from an object to be recognized, wherein the filter device is configured to filter the captured signals and to then supply them to the analysis device, and wherein the analysis device is configured to recognize the object by analysing the supplied filtered signals, - wherein the filter device has an averaging unit which is configured to average the profile of the amplitudes of the captured signals over time, - wherein the filter device has a non-linear filter unit which is provided on the basis of a linear low-pass filter with a variable time constant and is configured to filter the captured signals, - wherein the object recognition apparatus is configured, in order to analyse and recognize the object , to supply a value profile corresponding to the difference between the averaged amplitude profile over time and the filtered signals, as determined by means of a component , to the analysis device, and - wherein the object recognition apparatus is configured to set the variable time constant on the basis of the deviation between the filtered signals and the captured signals, as determined by means of a deviation calculation component , and on the basis of the averaged amplitude profile. - wherein the filter device has an averaging unit which is configured to average the profile of the amplitudes of the captured signals over time, - wherein the filter device has a non-linear filter unit which is provided on the basis of a linear low-pass filter with a variable time constant and is configured to filter the captured signals, - wherein the object recognition apparatus is configured, in order to analyse and recognize the object , to supply a value profile corresponding to the difference between the averaged amplitude profile over time and the filtered signals, as determined by means of a component , to the analysis device, and - wherein the object recognition apparatus is configured to set the variable time constant on the basis of the deviation between the filtered signals and the captured signals, as determined by means of a deviation calculation component , and on the basis of the averaged amplitude profile.
A method for service transmission, comprising: obtaining , by a core network device , a quality of service (QoS) profile for transmitting a multicast service; and transmitting , by the core network device , the QoS profile to an access network device , the QoS profile being used for the access network device to transmit a target service, wherein the QoS profile comprises a first QoS profile and a second QoS profile, wherein the first QoS profile is used for transmitting a unicast service and the second QoS profile is used for transmitting the multicast service, and wherein the unicast service and the multicast service are transmitted using a same QoS flow in a protocol data unit, PDU, session. obtaining , by a core network device , a quality of service (QoS) profile for transmitting a multicast service; and transmitting , by the core network device , the QoS profile to an access network device , the QoS profile being used for the access network device to transmit a target service, wherein the QoS profile comprises a first QoS profile and a second QoS profile, wherein the first QoS profile is used for transmitting a unicast service and the second QoS profile is used for transmitting the multicast service, and wherein the unicast service and the multicast service are transmitted using a same QoS flow in a protocol data unit, PDU, session.
An optical method for use in determining in vivo hemorheological chemical and physiological parameters of a subject, the method comprising: (i) applying partially or entirely coherent light generated by a light source unit to a target region in said subject to cause a light response signal from the target region; (ii) detecting by means of a detection unit fluctuation dependent speckle pattern of the light response signal over a predetermined frequency interval, and generating data indicative thereof; (iii) processing by means of a control system the detected data by using power spectrum analyzing, which latter comprises computing a power spectrum integral upon the interval [2700 Hz, 10000 Hz]; and, (iv) determining by using the control system at least one desired parameter or condition of said subject from the time-fluctuation of a dynamic light scattering (DLS) signal, wherein the determined physiological parameter is a heart pulse rate or wherein the determined physiological parameter is a systolic and diastolic arterial blood pressure value and wherein the method further comprises applying by means of a controllable pressurizing assembly a controllable pressure to the subject so as to induce hemorheological variations artificially; and wherein the method further comprises the following steps performed by the control system: (i) rejecting low frequency component of the detected DLS signal by using high-pass filters; and (ii) processing high frequency components to eliminate motion artifacts. (i) applying partially or entirely coherent light generated by a light source unit to a target region in said subject to cause a light response signal from the target region; (ii) detecting by means of a detection unit fluctuation dependent speckle pattern of the light response signal over a predetermined frequency interval, and generating data indicative thereof; (iii) processing by means of a control system the detected data by using power spectrum analyzing, which latter comprises computing a power spectrum integral upon the interval [2700 Hz, 10000 Hz]; and, (iv) determining by using the control system at least one desired parameter or condition of said subject from the time-fluctuation of a dynamic light scattering (DLS) signal, (i) rejecting low frequency component of the detected DLS signal by using high-pass filters; and (ii) processing high frequency components to eliminate motion artifacts.
A lamp, having - a lamp housing and - an electronic circuit arranged on a printed circuit board , wherein the printed circuit board is designed and arranged in such a manner that an outer wall region of the lamp housing is formed by it, wherein the printed circuit board is fastened to the rest of the lamp housing by means of a screw connection and/or snappers and/or a lock and/or a plug-in unit, characterized in that the printed circuit board has an opening or a recess for the passage of a power supply cable of the lamp, wherein the printed circuit board and the rest of the lamp housing are designed so that when the printed circuit board arranged as intended free spaces are formed on two opposite sides of the printed circuit board , which are closed by casting. - a lamp housing and - an electronic circuit arranged on a printed circuit board ,
Kiln for firing ceramic blanks , in particular bricks, having a plurality of trains which comprise a number of kiln cars and are movable in parallel with one another and along a longitudinal kiln portion, and on which the blanks are to be arranged, the kiln portion having a firing zone for heating the blanks , trains which are arranged side-by-side being movable in opposite directions through a firing zone, without a reversal of direction, at least one fan being provided, each kiln car having wheels which are connected via an axle , and which are able to roll along a particular rail which has a corresponding abradable sealing element made of a mineral material, it being possible for adjacent wheels of adjacent kiln cars to roll on respective rails , between which a shared abradable sealing element made of the mineral material is arranged, characterised in that cooling tubes are arranged between the wheels of a kiln car which are connected via an axle and/or adjacent kiln cars having a slot on one side and a ridge on the other side and an adjacent kiln car having a ridge engaging in the slot of an adjacent kiln car in the manner of a tongue/groove system with a gap.
A pharmaceutical composition comprising an aryl hydrocarbon receptor (AhR) modulator of formula (Ia): wherein: X' is amino, which may be optionally substituted; n is 0-6; R 2 is heteroaryl, which may be optionally substituted; R 3 , R 4 , R 5 and R 6 are independently H, alkoxy, alkyl, or halo; and pharmaceutically acceptable salts thereof. X' is amino, which may be optionally substituted; n is 0-6; R 2 is heteroaryl, which may be optionally substituted; R 3 , R 4 , R 5 and R 6 are independently H, alkoxy, alkyl, or halo;
A dentifrice composition comprising: (a) from about 15% to 55%, by weight of the composition, of water: (b) from 20% to 40%, by weight of the composition, of bicarbonate salt; (c) from 0.01% to 10%, by weight of the composition, of neutral amino acid: and (d) from 0.0025% to 2%, by weight of the composition, of a fluoride ion source; and wherein the neutral amino acid is not complexed with zinc. (a) from about 15% to 55%, by weight of the composition, of water: (b) from 20% to 40%, by weight of the composition, of bicarbonate salt; (c) from 0.01% to 10%, by weight of the composition, of neutral amino acid: and (d) from 0.0025% to 2%, by weight of the composition, of a fluoride ion source; and
A method of texturing a silicon surface to reduce reflectivity, comprising: positioning a substrate with a silicon surface in a vessel , wherein the silicon surface comprises a plurality of copper particles; filling the vessel with a volume of an etching solution that covers the silicon surface of the substrate, wherein the etching solution comprises an oxidant-etchant solution that comprises an etching agent and a silicon oxidizing agent ; and etching the silicon surface by agitating the etching solution in the vessel, whereby the reflectivity of the silicon surface is reduced to less than about 10 percent; characterized in that the ratio of copper particle size to spacing on the silicon surface is about 3 to 5.
A delivery cable for delivering a medical device , the delivery cable comprising: a flexible inner core ; a proximal outer coil having a first rigidity; and a distal outer coil surrounding at least a portion of a distal section of the flexible inner core and having a second rigidity less than the first rigidity, thereby reducing bias placed on the medical device by the delivery cable. a flexible inner core ; a proximal outer coil having a first rigidity; and a distal outer coil surrounding at least a portion of a distal section of the flexible inner core and having a second rigidity less than the first rigidity, thereby reducing bias placed on the medical device by the delivery cable.
Electrochromic solution comprising: - a solvent; - a thickening polymer agent having a molecular weight of at least 200,000 g/mol; - at least one additive having a molecular weight between 300 and 50,000 g/mol; - a redox chemical mixture in solution in said solvent said mixture being constituted of at least one electrochromic reducing compound and at least one electrochromic oxidizing compound, and which colors in the presence of an applied voltage and which bleaches to a colorless condition in the absence of an applied voltage. - a solvent; - a thickening polymer agent having a molecular weight of at least 200,000 g/mol; - at least one additive having a molecular weight between 300 and 50,000 g/mol; - a redox chemical mixture in solution in said solvent said mixture being constituted of at least one electrochromic reducing compound and at least one electrochromic oxidizing compound, and which colors in the presence of an applied voltage and which bleaches to a colorless condition in the absence of an applied voltage.
A short-range optical amplification module, comprising: a first phase delay plate, a transflective mirror , a second phase delay plate and a reflective polarizing plate that are arranged sequentially, wherein: the transflective mirror includes a first optical surface and a second optical surface; the first optical surface is adjacent to the second phase delay plate; the second optical surface is a transflective optical surface, and the second optical surface is adjacent to the first phase delay plate; characterized in that the focal length fs2 of the reflection surface of the second optical surface meets the following condition: 1.5F≤fs2≤3F, wherein F is the system focal length of the short-range optical amplification module, and F meets the following condition: 10mm≤F≤35mm. the transflective mirror includes a first optical surface and a second optical surface; the first optical surface is adjacent to the second phase delay plate; the second optical surface is a transflective optical surface, and the second optical surface is adjacent to the first phase delay plate; characterized in that the focal length fs2 of the reflection surface of the second optical surface meets the following condition: 1.5F≤fs2≤3F, wherein F is the system focal length of the short-range optical amplification module, and F meets the following condition: 10mm≤F≤35mm.
A device for supplying a lubricant to a gear, or for oil cooling a piston in the engine of a motor vehicle, comprising a lubricant or oil distributor pipe having at least one spray pipe branching off therefrom for conveying said lubricant or oil to the respective components of the gear or engine, characterized in that said spray pipe comprises two half shells , which are permanently joined by material bonding in the region of the contact surfaces of the joining seam between the half shells .
An antibody or antigen-binding fragment thereof comprising: (i) light chain CDR1, CDR2 and CDR3 from a donor lagomorph antibody or antigen-binding fragment thereof and heavy chain CDR1, CDR2 and CDR3 from a donor lagomorph antibody or antigen-binding fragment thereof; (ii) a variable human light chain framework; and (iii) a variable human heavy chain framework that is at least 85% identical to the sequence of SEQ ID NO: 4 and comprises a threonine (T) at position 24 (AHo numbering). (i) light chain CDR1, CDR2 and CDR3 from a donor lagomorph antibody or antigen-binding fragment thereof and heavy chain CDR1, CDR2 and CDR3 from a donor lagomorph antibody or antigen-binding fragment thereof; (ii) a variable human light chain framework; and (iii) a variable human heavy chain framework that is at least 85% identical to the sequence of SEQ ID NO: 4 and comprises a threonine (T) at position 24 (AHo numbering).
A method for automatically measuring a subject's phoria while the subject fixates on a visual target, comprising: covering and uncovering at least one of the subject's eyes; illuminating the at least one of the subject's eyes with at least two lights using at least two light sources ; capturing a sequence of images of the at least one of the subject's eyes after uncovering the at least one of the subject's eyes using an image capturing device, the sequence of images including a first image and a second image including reflections of the at least two lights from at least one of the subject's eyes; analyzing the first image and the second image to identify respective positions of the reflections of the at least two lights within the at least one of the subject's eyes; and determining a phoria measurement based on the respective positions of the reflections of the at least two lights within the at least one of the subject's eyes . covering and uncovering at least one of the subject's eyes; illuminating the at least one of the subject's eyes with at least two lights using at least two light sources ; capturing a sequence of images of the at least one of the subject's eyes after uncovering the at least one of the subject's eyes using an image capturing device, the sequence of images including a first image and a second image including reflections of the at least two lights from at least one of the subject's eyes; analyzing the first image and the second image to identify respective positions of the reflections of the at least two lights within the at least one of the subject's eyes; and determining a phoria measurement based on the respective positions of the reflections of the at least two lights within the at least one of the subject's eyes .
A method of making a battery comprising: preparing a cathode active material by a process comprising treating lithium nickel oxide (LiNiO 2 ) with an aqueous acid solution, including contacting the oxide with an aqueous acid; incorporating the cathode active material into a cathode , the cathode further comprising a second cathode active material selected from the group consisting of electrolytic manganese dioxide, chemically-prepared manganese dioxide, acid-treated electrolytic manganese dioxide, acid-treated chemically-prepared manganese dioxide, and combinations thereof; and incorporating the cathode into a battery. preparing a cathode active material by a process comprising treating lithium nickel oxide (LiNiO 2 ) with an aqueous acid solution, including contacting the oxide with an aqueous acid; incorporating the cathode active material into a cathode , the cathode further comprising a second cathode active material selected from the group consisting of electrolytic manganese dioxide, chemically-prepared manganese dioxide, acid-treated electrolytic manganese dioxide, acid-treated chemically-prepared manganese dioxide, and combinations thereof; and incorporating the cathode into a battery.